Rare Diseases Symptoms Automatic Extraction
Home
A random Abstract
Our Project
Our Team
p38 (MAPK) stress signalling in replicative senescence in fibroblasts from progeroid and genomic instability syndromes.
[werner syndrome]
Werner
Syndrome
(
WS
)
is
a
human
segmental
progeria
resulting
from
mutations
in
a
DNA
helicase
.
WS
fibroblasts
have
a
shortened
replicative
capacity
,
an
aged
appearance
,
and
activated
p
38
MAPK
,
features
that
can
be
modulated
by
inhibition
of
the
p
38
pathway
.
Loss
of
the
WRNp
RecQ
helicase
has
been
shown
to
result
in
replicative
stress
,
suggesting
that
a
link
between
faulty
DNA
repair
and
stress-induced
premature
cellular
senescence
may
lead
to
premature
ageing
in
WS
.
Other
progeroid
syndromes
that
share
overlapping
pathophysiological
features
with
WS
also
show
defects
in
DNA
processing
,
raising
the
possibility
that
faulty
DNA
repair
,
leading
to
replicative
stress
and
premature
cellular
senescence
,
might
be
a
more
widespread
feature
of
premature
ageing
syndromes
.
We
therefore
analysed
replicative
capacity
,
cellular
morphology
and
p
38
activation
,
and
the
effects
of
p
38
inhibition
,
in
fibroblasts
from
a
range
of
progeroid
syndromes
.
In
general
,
populations
of
young
fibroblasts
from
non-
WS
progeroid
syndromes
do
not
have
a
high
level
of
cells
with
an
enlarged
morphology
and
F-
actin
stress
fibres
,
unlike
young
WS
cells
,
although
this
varies
between
strains
.
p
38
activation
and
phosphorylated
HSP
27
levels
generally
correlate
well
with
cellular
morphology
,
and
treatment
with
the
p
38
inhibitor
SB
203580
effects
cellular
morphology
only
in
strains
with
enlarged
cells
and
phosphorylated
HSP
27
.
For
some
syndromes
fibroblast
replicative
capacity
was
within
the
normal
range
,
whereas
for
others
it
was
significantly
shorter
(
e
.
g
.
HGPS
and
DKC
)
.
However
,
although
in
most
cases
SB
203580
extended
replicative
capacity
,
with
the
exception
of
WS
and
DKC
the
magnitude
of
the
effect
was
not
significantly
different
from
normal
dermal
fibroblasts
.
This
suggests
that
stress-induced
premature
cellular
senescence
via
p
38
activation
is
restricted
to
a
small
subset
of
progeroid
syndromes
.
Diseases
Validation
Diseases presenting
"small subset"
symptom
child syndrome
cushing syndrome
hereditary cerebral hemorrhage with amyloidosis
hodgkin lymphoma, classical
primary effusion lymphoma
werner syndrome
zellweger syndrome
You can validate or delete this automatically detected symptom
Validate the Symptom
Delete the Symptom